Evidence map›Paper›PMID 39671590›Full record

ArticleJournal of medical Internet research2024

Personalized Mobile App-Based Program for Preparation and Recovery After Radical Prostatectomy: Initial Evidence for Improved Outcomes From a Prospective Nonrandomized Study.

Alberto Martini, Claudia Kesch, Alae Touzani, Giorgio Calleris, Bogdan Buhas, Rawad Abou-Zahr, Razvan-George Rahota, Benjamin Pradère, Christophe Tollon, Jean-Baptiste Beauval and 1 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alberto MartiniDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0003-1272-7154
Claudia KeschDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0002-2656-2664
Alae TouzaniDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0003-3087-3518
Giorgio CallerisDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0003-3831-1632
Bogdan BuhasDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0002-5981-3802
Rawad Abou-ZahrDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0003-4241-3738
Razvan-George RahotaDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0003-2875-2936
Benjamin PradèreDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0002-7768-8558
Christophe TollonDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0009-0005-8705-5454
Jean-Baptiste BeauvalDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0002-1532-015X
Guillaume PloussardDepartment of Urology, La Croix du Sud Hospital, Quit Fonsegrives, France.ORCID 0000-0002-6004-2152

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundeHealth can help replicate the benefits of conventional surgical prehabilitation programs and overcome organizational constraints related to human resources and health care-related costs.

objectiveWe aimed to assess the impact of an optimized perioperative program using a personalized mobile app designed for preparation and recovery after radical prostatectomy (RP).

methodsWe report on a series of 122 consecutive robot-assisted RP before and after the implementation of the betty.care app (cohort A: standard of care, n=60; cohort B: optimized program, n=62). The primary end point was continence recovery, defined as "0 or 1 safety pad per day" at 6 weeks after surgery. Secondary end points were length of stay, same-day discharge, complications, readmissions, and number of days alive and out of hospital within 30 days from surgery.

resultsBoth cohorts were comparable in terms of age, prostate-specific antigen, prostate volume, and disease aggressiveness. Intraoperative parameters (lymph node dissection, operative time, and bilateral nerve-sparing surgery) were comparable in both groups, except for blood loss, which was significantly higher in cohort B (182 vs 125 cc; P=.008). The 6-week continence rate was improved in cohort B in both univariable and multivariable analyses (92% vs 75%; P=.01). There were trends favoring cohort B for all secondary end points with a minimal 30% benefit compared with cohort A. Grade 2 or more complications occurred less frequently in cohort B (13% vs 3.2%; P=.042). Same-day discharge and readmission rates were 35% and 53% (P=.043), and 3.3% and 1.6% (P=.54) in cohorts A and B, respectively. Mean length of stay was reduced by 0.2 days in cohort B (0.58 vs 0.78 days; P=.10). The main limitation was the absence of randomization.

conclusionsThe implementation of a mobile app that provides a holistic approach to the perioperative period, integrating prehabilitation, rehabilitation, and remote monitoring, could lead to the improvement of important functional outcomes after RP and could replicate an on-site prehabilitation program. Multicenter validation is needed.

Indexed as

Mobile ApplicationsProstatectomyAgedHumansLength of StayMaleMiddle AgedProspective StudiesProstatic NeoplasmsRobotic Surgical ProceduresTreatment Outcomeappbetty.care appcohortcontinenceeHealthelectronic healthhealth carehuman resourceimplementationmHealthmobile appmobile healthperioperativeprehabilitationradical prostatectomyrehabilitationrobot, outcomessingle-surgeonsurgical

Identifiers

PMID39671590
PMCPMC11681284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.